12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks experienced significant movements. Telesis Bio (TBIO) saw a 32.5% increase, while vTv Therapeutics (VTVT) faced a sharp 96.8% decline. Other notable gainers include Femasys (FEMY), Medigus (MDGS), TC BioPharm (TCBP), Assembly Biosciences (ASMB), and PaxMedica (PXMD). On the losing side, Impel Pharmaceuticals (IMPL), Aethlon Medical (AEMD), Ikena Oncology (IKNA), Biophytis (BPTS), and Heart Test Laboratories (HSCS) saw declines ranging from 10.56% to 31.96%.
November 24, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aethlon Medical shares decreased by 17.16% to $1.4, with a market cap of $3.4 million.
The pre-market decline could be a bearish signal for Aethlon Medical's stock in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Biophytis shares fell 10.74% to $0.7, with a market cap of $6.8 million.
The pre-market decline suggests potential negative momentum for Biophytis's stock in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Heart Test Laboratories stock decreased by 10.56% to $0.21, with a market cap of $10.2 million.
The pre-market drop may reflect investor concerns, potentially leading to a negative short-term impact on the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Ikena Oncology shares declined by 12.27% to $1.43, with a market cap of $69.0 million.
A double-digit percentage drop in pre-market trading often indicates negative investor sentiment and could lead to further declines.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Impel Pharmaceuticals stock declined by 31.96% to $0.53, with a market cap of $12.6 million.
Such a significant drop in pre-market could suggest negative sentiment or news, likely affecting the stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
vTv Therapeutics shares plummeted by 96.8% in pre-market trading.
A drastic pre-market decline is typically a negative indicator and could suggest a continued downtrend in the short term.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Assembly Biosciences stock moved upwards by 9.99% to $0.71, with a market cap of $46.7 million.
The stock's pre-market performance could be a positive indicator for its short-term trajectory.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Femasys shares increased by 14.9% to $1.05 with a market cap of $22.7 million.
The pre-market gain for Femasys suggests positive momentum that could carry into the regular trading session.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Medigus stock rose 10.99% to $3.13, with a market cap of $5.3 million.
A double-digit percentage rise in pre-market can be a bullish sign for the stock's performance during the upcoming session.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
PaxMedica shares moved upwards by 9.8% to $1.12, with a market cap of $1.2 million.
The pre-market gain may indicate a positive market reaction, potentially leading to a short-term positive performance.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Telesis Bio shares surged 32.5% in pre-market trading with a market cap of $15.8 million.
A significant pre-market increase often indicates positive investor sentiment which could lead to a short-term price rise.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
TC BioPharm stock rose 10.0% to $0.55, with a market cap of $5.1 million.
The pre-market increase could reflect investor confidence, potentially leading to a short-term uptrend.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 80